Skip to main navigation Skip to search Skip to main content

Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individuals

  • C. I. Müller*
  • , Q. T. Luong
  • , L. Y. Shih
  • , L. C. Jones
  • , J. C. Desmond
  • , N. Kawamata
  • , O. Tcherniantchouk
  • , Q. Liu
  • , K. Ito
  • , M. Osato
  • , Y. Ito
  • , A. Tefferi
  • , S. de Vos
  • , H. P. Koeffler
  • *Corresponding author for this work
  • University of California at Los Angeles
  • University of Freiburg
  • University of Birmingham
  • Chang Gung Memorial Hospital
  • Cedars-Sinai Medical Center
  • National University of Singapore
  • Agency for Science, Technology and Research, Singapore
  • Mayo Clinic Rochester, MN

Research output: Contribution to journalJournal Article peer-review

10 Scopus citations
Original languageEnglish
Pages (from-to)1773-1778
Number of pages6
JournalLeukemia
Volume22
Issue number9
DOIs
StatePublished - 2008
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this